Administration of 60 pmoles of 1,25-dihydroxycholecalciferol to vitamin D-deficient rats on a low calcium diet gives a maximal intestinal calcium transport response in 7 hr and a maximal bone calcium mobilization response in 12 hr. During the 48 hr after injection of radioactive 1,25-dihydroxycholecalciferol, unchanged 1,25-dihydroxycholecalciferol accounts for 71-98% of the radioactivity found in the intestine with minor amounts appearing in more polar metabolites. In the bone, for the 1st 12 hr, 1,25-dihydroxycholecalciferol is the major form (75-82%) present while at 24 hr, the amount of 1,25-dihydroxycholecalciferol decreases with a corresponding rise in the amounts of metabolites both less polar and more polar than the 1,25-dihydroxycholecalciferol. Since these metabolies are at their highest concentration when bone calcium mobilization is decreasing, they are most likely not responsible for the calcium mobilization observed during the 1st 12 hr. The appearance of water-soluble radioactivity in the kidney, plasma, liver, and muscle 24 hr after 1,25-dihydroxycholecalciferol injection has been demonstrated. The present results suggest that, although 1,25-dihydroxycholecalciferol is converted to further metabolites in the rat, it is probably the form of vitamin D responsible for initiating intestinal calcium transport and bone calcium mobilization. 
INTRODUCTION
That vitamin D must be metabolized to polar metabolites before it can function is an idea that has been developed during the past few years. This idea obtained a firm foothold with the demonstration that, after a 10 IUl dose of vitaimiin D3-'H to a rat, there appeare(l a major polar metabolite fraction that retained the biological activity of the parent vitamin (1) . This metabolite has since been isolated and identified as 25-hvdroxvcholecalciferol (25-OHD.,)' (2). It is not, hlowever, the final metabolically kcceivcd for Piub)lication 19 .1fi 19,72 ,,,,.1 i '-'ist', form 5 an(l converts it to more polar metabolites (3, 4) , the most important of which has been unequivocally identified as 1,25-(OH)2D3 (5, 6) . Supporting evidence for this structure was provided independently by Lawson, Fraser, Kodicek, 'Morris. and WNilliams with partially purified material from kidney lhonmogenates (7) .
The question as to whletlher 1,25-(OH)2D3 is the final tissue active metabolite of vitamin D now becomes apparenit. In the intestine, 1,25-(OH')2D has been shown to act miore rap)idlv than 25-OHD3 in initiating calcium tranL1ssport (8, 9) . Furthermore, in contrast to the 25-OHD3 response, the intestinal calcium absorption stimulation by 1,25-(OH)2D3 is not blocked by prior administration of actinomvcin D (10) . Recently, it has also been shown in chicks that, at the time w\hen intestinal calcium transport has reached a maximal rate in response to 1,25-(OH)2D3, only this metabolite is detectable in the intestine (11) . Furthermore, in nephrectomized rats, the intestine responds only to 1,25-(OH)2D3 and not to 25-OHD3, (12) . It therefore appears that, at least in the chick. 1,25-(OH) 2D3, and not a further metabolite, is the active form of vitamin D in initiating the intestinal calcium transport system.
Like the intestinal response, there is a quicker induction of the bone calcium mobilization system after 1,25-(OH)2D3 than after an equivalent (lose of 25-OHD, (13) . Also, in fetal bone tissue cultures, 1.25-(OH')2D3 will cause bone calcium mobilization at concentrations much less than 25-OHD3 (14) . However, in contrast to the intestine. the bone calcium mobilization response to both 1,25-(OH) 2D3 and to 25-OHD3 is actinomvcin D sensitive (13 Ci/mmole) (17) using the in vitro chick kidney incubation system previously described by Gray, Boyle, and DeLuca (4) as modified by Boyle, Miravet, Gray, Holick, and DeLuca (12 27-3H]-1,25-(OH)2D3 dissolved in 0.05 ml of 95% ethanol. After the required time interval, the animals were sacrificed. Plasma obtained from each rat was separated from the heparinized blood by centrifugation, and its radioactivity determined (11) . The plasma from all rats at each time point was then combined. The first 50 cm of the small intestine were removed, washed in saline, split open, and washed again. The mucosa was then scraped off with a microscope slide. In addition, the kidneys, liver, both the hind-and forelegs, and a sample of muscle were removed. The individual tissues from all the rats in a group at a particular time point were pooled.
Plasma and 20% homogenates in water of the intestinal mucosa, kidney, and liver were extracted and counted as described earlier (11) . The hind-and forelegs were dissected free from adhering muscle and ligaments, split lengthwise to facilitate removal of bone marrow, and weighed. The bone sections were then allowed to cool on solid C02
and pulverized in a mortar and pestle maintained near the temperature of the solid C02. The frozen, pulverized bone was immediately mixed with 200 ml of methanol-chloroform (2:1, v/v) and stirred overnight under N2 and at 4VC.
A portion of the final solution was counted (11) . This measurement was taken to be the radioactivity present in the whole tissue. Then 100 ml of chloroform and 80 ml of distilled water were added to separate the phases. The water phase was reextracted with 100 ml of chloroform and the two chloroform layers combined and samples counted. The muscle was frozen, ground, and extracted by a similar method. The amount of radioactivity in the water phase was determined by subtracting the chloroformsoluble radioactivity from the radioactivity found in the whole homogenate before extraction.
Chromatography. The chloroform layers from the tissue extracts were evaporated with a flash evaporator and the lipid that remained behind after removal of the residual water as an azeotrope with 100%o ethanol was redissolved in chloroform: Skellysolve B: methanol (75: 23: 2). The sample was applied to the Sephadex LH-20 column described previously (11) Radioactive measurements. Radioactivity in the tissue homogenates, plasma, chloroform-soluble phases, and column effluents were determined as previously described (11) . The samples were counted in a Packard Tri-Carb liquid scintillation counter, model 3003 (Packard Instrument Co., Inc., Downers Grove, Ill.) equipped with an automatic external standardization system.
RESULTS
Biological activity. The response of the intestinal calcium transport system to 60 pmoles of 1,25-(OH) 2D3 is (Fig. 2) , while the 1,25-(OH)2D3-3H is certainly present in intestine at that time (Table II) , revealing a definite lag in the action of 1,25-(OH)2D3 on intestinal calcium transport.
In bone from 1 to 12 hr after injection of 1,25-(OH)2Ds, that is when the bone calcium mobilization response is maximal, 75-82% of the bone radioactivity is present as 1,25-(OH)2Ds (Table III) . However, at 24 hr, the time when the bone calcium mobilization response is beginning to decline, the metabolite picture changes sharply. There is a drop in the per cent of bone radioactivity appearing in the 1,25-(OH)2D3 region of the column effluent and a corresponding increase in radioactivity appearing in two peaks less polar than 1,25-(OH)2D3. At 48 hr, there was not a sufficient amount The animals were treated as described in Table III Table V . As has been previously demonstrated in the chick (11) , the dose disappears from the plasma very rapidly. Assuming the blood represents 6%of the total body weight, at 1 hr after injection there is only 27.8±6.5% of the total dose in the plasma. The remainder of the dose appears distributed among the various tissues with the highest concentrations at 1 hr, appearing in the liver and intestine.
As has been mentioned previously, the intestine and bone radioactivity remain chloroform soluble up to 48 hr after dosage. This is in contrast to the other tissues studied where at 24 hr there is up to 55% of the radioactivity present in the tissues found in the water layer after chloroform-methanol extraction. Also of interest is the apparent rebound of radioactivity in the bone, kidney, and muscle 24 hr after dosage of 1,25-(OH)2D3. It is at this time that the radioactivity in the muscle and kidney becomes more water soluble while that found in the bone remains chloroform soluble but, as shown in Table III, becomes less polar than the the 1,25-(OH)2D3.
When the radioactivity is extracted from the tissues and the lipid extracts applied to the Sephadex LH-20 columns, the metabolite picture shown in Table VI is obtained. The liver shows the fastest decrease in 1,25-(OH) 2D3 with a corresponding increase in the watersoluble radioactivity. The intestine (Table I) and plasma show no metabolites less polar than 1,25-(OH)2D3. These less polar nmetabolites appear to concentrate in the bone (Table III) The animals were treated as described in Table V nificant roles for these radioactive compounds cannot be ruled out. Further work must be done to determine the importance of the water-soluble radioactivity and of both the radioactivity that is less polar and more polar than the 1,25-(OH)2D3. It is of interest that although 1,25-(OH)2Ds is in the intestine 1 hr after dosage, the intestinal calcium transport response has not yet been stimulated (Fig. 2) . In rats, the intestinal calcium transport response to 1,25-(OH)2Ds is not blocked by actinomycin D which suggests transcription of genetic information is not involved (10) . The lag which obviously exists may mean that a transport system may be assembled from existing but unread messenger RNA's or from precursor components.
It seems unlikely that there is a direct involvement of 1 25-(OH)2D3 in the transport mechanism per se simply because of the lag. The response of bone to 1,25-(OH) 2Ds is actinomycin sensitive which suggests that RNA and protein synthesis is involved in this mechanism (13) .
In tny case, it seems that the 1,25-(OH)2Ds will be of great value in unraveling the mechanisms involved.
